Ok, since I’m at the computer a lot today, as I slowly come to the realization that I have to work, I’m just going to keep typing about the abomination that is IFRX. Why exactly did IFRX get in their business? What inspired them to research this specific affliction? While there may be more than 3Million affected on a yearly basis, the fact that there are no known cures in todays modern level of medical care calls to question the motivations.
In Chapter 6, we cover cost leadership and environmental threats. Did IFRX enter this field because there were no known threats? there were no rivals? Was this a purely monetary decision? Was there something else? Entering the biotech industry takes millions and a lot of time. Researchers need the proper equipment, the proper facilities, and the right mix of fellow researchers to make the process flow freely and correct. Maybe the original founders identified weakness in the industry and capitalized their timing to enter the field at this specific point. By being the first entrant, they immediately increased the cost bar for following entrants before they even started their first day. As more entrants join a market, the cost to enter is exponentially increased as the technology, time, and resources that have been utilized thus far demonstrates that less resources remain, with less options available for success. IFRX has this market closed at this time, unless they continue to fail in research, and financial incentives are moved elsewhere.
IFRX 